These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11328193)

  • 1. Losigamone add-on therapy in partial epilepsy: a placebo-controlled study.
    Bauer J; Dienel A; Elger CE;
    Acta Neurol Scand; 2001 Apr; 103(4):226-30. PubMed ID: 11328193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Losigamone in partial seizures: a randomized double-blind study.
    Baulac M; Klement S;
    Epilepsy Res; 2003 Aug; 55(3):177-89. PubMed ID: 12972172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
    Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
    Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial.
    Brodie MJ; Rosenfeld WE; Vazquez B; Sachdeo R; Perdomo C; Mann A; Arroyo S
    Epilepsia; 2009 Aug; 50(8):1899-909. PubMed ID: 19490053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures.
    Elger C; Bialer M; Cramer JA; Maia J; Almeida L; Soares-da-Silva P
    Epilepsia; 2007 Mar; 48(3):497-504. PubMed ID: 17319919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
    Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.
    Faught E; Holmes GL; Rosenfeld WE; Novak G; Neto W; Greenspan A; Schmitt J; Yuen E; Reines S; Haas M
    Neurology; 2008 Nov; 71(20):1586-93. PubMed ID: 19001248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.
    Gil-Nagel A; Lopes-Lima J; Almeida L; Maia J; Soares-da-Silva P;
    Acta Neurol Scand; 2009 Nov; 120(5):281-7. PubMed ID: 19832771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide as adjunctive therapy for refractory partial seizures.
    Brodie MJ
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S11-6. PubMed ID: 16316744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losigamone add-on therapy for partial epilepsy.
    Xiao Y; Luo M; Wang J; Luo H
    Cochrane Database Syst Rev; 2012 Jun; (6):CD009324. PubMed ID: 22696384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying baseline characteristics of placebo responders versus nonresponders in randomized double-blind trials of refractory partial-onset seizures.
    Niklson I; Edrich P; Verdru P
    Epileptic Disord; 2006 Mar; 8(1):37-44. PubMed ID: 16567324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.